| http://dbpedia.org/ontology/abstract
|
aTyr Pharma is a public biotherapeutics co … aTyr Pharma is a public biotherapeutics company (Nasdaq: LIFE) that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases. The company's lead product candidate, ATYR1923, is a selective modulator of Neuropilin-2 (NRP2) that downregulates both the innate and adaptive immune responses in inflammatory disease states. aTyr is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung disease (ILD), a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need. ATYR1923 is currently being investigated in a clinical trial in pulmonary sarcoidosis patients. The company was founded in 2005 and is headquartered in San Diego, California, and led by CEO Sanjay S. Shukla.lifornia, and led by CEO Sanjay S. Shukla.
|
| http://dbpedia.org/ontology/foundingYear
|
2005
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Sanjay_S_Shukla +
|
| http://dbpedia.org/ontology/locationCity
|
http://dbpedia.org/resource/San_Diego%2C_California +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
44
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Atyr_Logo.png?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageID
|
54745539
|
| http://dbpedia.org/ontology/wikiPageLength
|
7379
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1050891025
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Homeostasis +
, http://dbpedia.org/resource/The_Scripps_Research_Institute +
, http://dbpedia.org/resource/Bruce_Beutler +
, http://dbpedia.org/resource/Polaris_Partners +
, http://dbpedia.org/resource/Pulmonary_sarcoidosis +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Interstitial_lung_disease +
, http://dbpedia.org/resource/Sofinnova_Ventures +
, http://dbpedia.org/resource/Claude_Bernard +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Diego +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Biopharmaceutical +
, http://dbpedia.org/resource/Alta_Partners +
, http://dbpedia.org/resource/Russell_Microcap_Index +
, http://dbpedia.org/resource/San_Diego%2C_California +
, http://dbpedia.org/resource/Walter_Cannon +
, http://dbpedia.org/resource/Sanjay_S_Shukla +
, http://dbpedia.org/resource/Neuropilin-2 +
, http://dbpedia.org/resource/TRNA +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Aminoacyl_tRNA_synthetase +
, http://dbpedia.org/resource/Xiang-Lei_Yang +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Paul_Schimmel +
, http://dbpedia.org/resource/Ligase +
, http://dbpedia.org/resource/Pharmaceutical +
|
| http://dbpedia.org/property/hqLocationCity
|
http://dbpedia.org/resource/San_Diego%2C_California +
|
| http://dbpedia.org/property/hqLocationCountry
|
United States
|
| http://dbpedia.org/property/keyPeople
|
http://dbpedia.org/resource/Sanjay_S_Shukla +
|
| http://dbpedia.org/property/logo
|
Atyr Logo.png
|
| http://dbpedia.org/property/logoSize
|
250
|
| http://dbpedia.org/property/name
|
aTyr Pharma, Inc.
|
| http://dbpedia.org/property/numEmployees
|
44
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Start_date_and_age +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Ubl +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Lowercase +
, http://dbpedia.org/resource/Template:Url +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Diego +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/ATyr_Pharma?oldid=1050891025&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Atyr_Logo.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/ATyr_Pharma +
|
| http://xmlns.com/foaf/0.1/name
|
aTyr Pharma, Inc.
|
| owl:sameAs |
https://global.dbpedia.org/id/2oS9L +
, http://www.wikidata.org/entity/Q30286352 +
, http://dbpedia.org/resource/ATyr_Pharma +
|
| rdf:type |
http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Agent +
|
| rdfs:comment |
aTyr Pharma is a public biotherapeutics co … aTyr Pharma is a public biotherapeutics company (Nasdaq: LIFE) that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases. The company's lead product candidate, ATYR1923, is a selective modulator of Neuropilin-2 (NRP2) that downregulates both the innate and adaptive immune responses in inflammatory disease states. aTyr is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung disease (ILD), a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need. ATYR1923 is currently being investigated in a clinical trial in pulmonary sarcoidosis patients.l trial in pulmonary sarcoidosis patients.
|
| rdfs:label |
ATyr Pharma
|
